EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to ... read more
Source: PubMedPublished on 2023-05-23By Thomas E H Justesen
Related Articles:
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- How to Work Full Time & Live Well with Parkinson’s September 17, 2020 One of the most common challenges people with Parkinson’s face is balancing treatment with everyday activities and responsibilities. Exercising, going to medical appointments, attending support groups, focusing on your mental health, and all the other necessities that help you live well with Parkinson’s require a lot of time and energy. For people working when diagnosed, finding a way to balance these demands with their career responsibilities can seem impossible. A member of our community…
- The What, Why, and How of Community Action Committees (CACs) January 20, 2021 In our post announcing our Healthy Parkinson’s Communities initiative, we outlined our three goals: Ensure Parkinson’s community leaders have the knowledge and resources they need to make a positive and sustainable change in their community Encourage and support data-informed initiatives designed to increase access to and engagement with resources that improve the quality of life for people with Parkinson’s Work with communities to raise awareness…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Cannabis and Parkinson’s: What to Know About Medical Marijuana, CBD, and more March 25, 2021 Although there is insufficient evidence that recommends using cannabis to treat Parkinson’s motor symptoms, a growing number of people with Parkinson’s are experimenting with it to help ease their symptoms. Others who have not experimented with cannabis products, such as medical marijuana and CBD, are expressing more interest in the subject. Yet, many people do not fully understand the chemical and biological makeup of cannabis plants, the different types of cannabis products, and what the research says about the effects on Parkinson’s symptoms. A February 2021 study, published in the Journal of Parkinson’s Disease, reported that while…
- What You Need to Know about Cycling with Parkinson’s September 15, 2020 So, you want to ride a bike? That’s fabulous! We’re behind you all the way. But we also want to make sure you stay safe and healthy while doing so. So, whether you’re about to take your first or fiftieth ride since your Parkinson’s diagnosis, here’s what you need to know. #1 – Cycling is good for you Research shows that people with Parkinson’s experience significant benefits from pushing pedals on…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- What to know about hospital stays and Parkinson’s March 16, 2021 When you’re living with Parkinson’s, hospital stays—planned or unplanned—require special consideration. Here, we’ll share how to prepare for a hospital stay, where to find helpful worksheets, checklists, and kits to take with you, and additional information that can keep you feeling your best during and after your stay. Prepare Yourself for Changing Symptoms Your motor symptoms can worsen when you…
- Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism May 23, 2023 EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to…
- Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism May 23, 2023 EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to…
- Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism May 23, 2023 EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to…
- Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism May 23, 2023 EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to…
- Sertraline treatment influences [18F]FE-PE2I PET imaging for Parkinsonism May 23, 2023 EJNMMI Res. 2023 May 23;13(1):46. doi: 10.1186/s13550-023-01000-6.ABSTRACTBACKGROUND: The dopamine transporter (DaT) PET ligand [18F]FE-PE2I is used to aid the diagnosis of Parkinson's disease. After encountering four patients with a history of daily sertraline use, who all showed atypical findings on [18F]FE-PE2I PET, we suspected that the selective serotonin reuptake inhibitor (SSRI), sertraline, might interfere with the results and lead to…
- 5 Simple Exercises to Train Your Balance & Live Well with Parkinson’s March 1, 2021 Because Parkinson’s can impact the reflexes needed to maintain an upright posture, people with Parkinson’s may feel unstable while standing upright. This postural instability — better known as poor balance and coordination — can make certain physical activities difficult, and it also increases the risk of falling. The good news is that although postural instability is a common Parkinson’s symptom, it can be managed and mitigated with practice. By training your balance frequently, you can improve your postural stability and even regain some of your automatic balance reflexes. …
- How Sunlight Can Help You Live Well with Parkinson’s March 12, 2021 The human body was built to work in partnership with the sun. Its light can transform our moods, focus, sleep, energy levels, immune systems, bone density, and mental health. As a result, spending time in the sun can be particularly beneficial to people living with Parkinson’s who experience symptoms like depression, apathy, poor sleep, pain, and fatigue. And all you need to…
- Formularies, Insurance, and Parkinson’s September 11, 2020 Navigating health insurance is challenging even for people in the best of health, but when you need a variety of medications to treat your motor and non-motor Parkinson’s symptoms, it can feel even more overwhelming. Having a basic understanding of how insurance companies cover prescription medications, though, can help you get the care you need. Here, we’ll explore how formularies work, and we’ll share information about how your medications are covered, how you can make the most out…
- Turning Data into Action March 3, 2021 Your CAC is ready to roll. You have conducted research and completed a community healthy assessment for Parkinson’s (CHAP). Now, what? The transition from data collection to action can be difficult for some groups. But it’s a crucial transition; it maintains the group’s momentum and engagement and helps the group build self-efficacy. (We’ve all been part of those committees that meet to talk a lot and then lose steam because they never act. We want to…
- Building Your Parkinson’s Care Team April 7, 2021 Living well with Parkinson’s means living well in all aspects of your life—physical, mental, social, spiritual. One provider can’t possibly treat every part of your life, so, ideally, over time, you will build a holistic, integrated care team and plan that is personalized to YOUR symptoms, needs, and goals. In the beginning, your primary care physician and neurologist or movement disorder specialist may be the only two people you need on…
- 2016 Tai Chi Study Funded by the Davis Phinney Foundation Continues to Help People Live Well with Parkinson’s April 2, 2021 Before he enrolled in a research study about Tai Chi’s impacts on Parkinson’s symptoms, Rob Scott had never practiced the art. Now, five years later, it is an integral part of his life, helping him live well with Parkinson’s at 67. “Tai Chi feels like a kind of meditation. A kind of paying attention and letting go at the same time.” Rob was one of the participants in a…
- A Day in the Life of a Parkinson’s Ambassador: Patti Burnett April 5, 2021 Our Davis Phinney Foundation Ambassadors are at the heart of our organization. They are our fearless leaders dedicated to living well today, who use their knowledge, passion, and experience to support others going through a Parkinson’s journey. Each Monday during Parkinson’s Awareness Month, we will highlight a “Day in the Life” of one of our amazing Ambassadors. This week, we…
- When Parkinson’s OFF Gets in the Way of Life December 8, 2020 Parkinson’s looks different for everyone, and so do Parkinson’s OFF times. Some people living with Parkinson’s know they are OFF when their motor symptoms, such as tremor, rigidity, slowness, and stiffness return. Others may be aware that as their medications wear off, they feel increased anxiety, fatigue, depression, or pain. Some people with Parkinson’s may not even be aware that what they are feeling…
- Monthly research review: February 2020 February 29, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…